Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program
Clinical trial NCT01922193 · COMPLETED
Trial details
- NCT number
- NCT01922193
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-02-01
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.